Search
Sep 14, 2024
Bicycle Therapeutics CEO Kevin Lee highlights the company's data at the 2024 ESMO Congress
He discusses data from the Nectin-4 targeting zelenectide pevedotin program, Nectin-4 + CD137, and EphA2.
May 3, 2024
The CEO of Bicycle Therapeutics illustrates the form and function of bicycles and highlights the company's programs
Kevin Lee shows us what a bicycle looks like and compares and contrasts them to traditional antibodies.
.png){kind=logo}
